Role of bradykinins and nitric oxide in the AT2 receptor-mediated hypotension

Journal of Human Hypertension

Volumn 14, Issue , 2000, Pages S40-S46

  Sosa Canache, B ^a   Cierco, M ^b   Gutierrez, C Inès ^b   Israel, Anita ^c  

^a UNIVERSIDAD CENTROCCIDENTAL LISANDRO ALVARADO   (Venezuela)

^b Universidad Nacional Experimental Francisco de Miranda   (Venezuela)

^c UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

Angiotensin AT2 receptor; Footshocks; Kinins; Losartan; Nitric oxide synthase; PD 123319

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR; BRADYKININ; ICATIBANT; LOSARTAN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; CONFERENCE PAPER; CONTROLLED STUDY; DEPRESSOR RESPONSE; ENZYME ACTIVITY; HEART RATE; HYPOTENSION; MALE; NONHUMAN; PRESSOR RESPONSE; RAT; RECEPTOR BLOCKING; SHOCK;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BRADYKININ; DRUG ADMINISTRATION ROUTES; ENZYME INHIBITORS; HEAT; HYPERTENSION; HYPOTENSION; IMIDAZOLES; LOSARTAN; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RECEPTORS, BRADYKININ; SHOCK; VASODILATION;

EID: 0034081821     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000986     Document Type: Article

References (48)

1. Reit E. Actions of angiotensin on the adrenal medulla and autonomic ganglia. Fed Proc 1972; 31: 1338-1343.
2. Wong PC et al. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD 123177 (AII-2). J Pharmacol Exp Ther 1990; 255: 584-592.
3. Wong PC, Hart SD, Timmermans PBMWM. Effect of angiotensin II antagonism on canine renal sympathetic nerve function. Hypertension 1991; 17: 1127-1134.
4. Wong PC, Bernard R, Timmermans PBMWM. Effect of blocking angiotensin II receptor subtype on rat sympathetic nerve function. Hypertension 1992; 19: 663-667.
5. Cierco M, Israel A. Role of angiotensin ATa receptor on the cardiovascular response to footshock. Euro J Pharmacol 1994; 251: 103-106.
6. Bunkenburg B et al. Prolonged angiotensin II antagonism in spontaneously hypertensive rats. Hemodynamic and biochemical consequences. Hypertension 1991; 18: 278-288.
7. Campbell WG, Donohue JA, Duket LH. Alterations in responses to bradykinin, angiotensin I, and angiotensin II during the induction phase of one-kidney, one-wrapped hypertension and associated arterial disease in rabbits. Am J Pathol 1990; 98: 457-463.
8. Scheuer DA, Perrone MH. Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angiotensin. Am J Physiol (Reglnteg Comp Physiol 33) 1993; 264: R917-R923.
9. Yamaguchi K, Nishimura H. Angiotensin II-induced relaxation of fowl aorta. Am J Physiol 1988; 255: R591-R599.
10. Toda N, Miyazaki M. Angiotensin-induced relaxation in isolated dog renal and cerebral arteries. Am J Physiol (Heart Circ Physiol 9) 1981; 240: H247-H254.
11. Harbel RL, Anneser F, Villringer A, Einhaupl KM. Angiotensin II induces endothelium-dependent vasodilation of rat cerebral arterioles. Am J Physiol (Heart Circ Physiol 27) 1990; 258: H1840-H18.
12. Harbel RL, Decker PJ, Einhaupl KM. Endothelium degradation products mediate endothelium-dependent dilatation of rabbit brain arterioles. Circ Res 1991; 68: 1621-1627.
13. Siragy HM, Carey RM. The subtype-2 ATJ angiotensin receptor regulates renal cyclic guanosine 3',5'-monophosphate and ATa receptor-mediated prostag-landine E2 production in conscious rats. J Clin Investig 1996; 97: 1978-1982.
14. Seyedi N, Xu X, Nasjletti A, Hintze TH. Coronary kinin generatin mediates nitric oxide release after angiotensin receptor stimulation. Hypertension (Dallas) 1995; 26: 164-170.
15. Wiemer G et al. The functional role of angiotensin II-subtype AT2-receptors in endothelial cells and isolated ischemic rat hearts. Pharm Pharmacol Lett 1993; 3: 24-27.
16. Phillips MI. Functions of angiotensin in the central nervous system. Annu Rev Physiol 1987; 49: 413-435.
17. Barbella Y, Cierco M, Israel A. Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on drinking behavior and renal actions of central administered renin. Proc Soc Exp Riol Med 1993; 202: 401-406.
18. Fregly MJ, Rowland NE. Effect of a nonpeptide angiotensin II receptor antagonist, losartan, on angiotensin-related water intake in rats. Brain Res Bull 1991; 27: 976-100.
19. Qadri F et al. Angiotensin Il-induced vasopressin release in mediated through alpha-1 adrenoceptors and angiotensin II ATa receptors in the supraoptic nucleus. J Pharmacol Exp Ther 1993; 267: 567-574.
20. Antonaccio MJ, Kervin L. Pre-and postjunctional inhibition of vascular function by captopril in SHR implication of vascular angiotensin II in hypertension and antihypertensive actions of captopril. Hypertension 1981; 3 (1): I-S4-I-S62.
21. Sumners C, Phillips IM. Central injection of angiotensin II alters catecholamine activity in rat brain. Am J Physiol 1983; 244: R257-R263.
22. Yang II EK et al. Effect of chronic central administration of DuP 753 on the cardiovascular and hormonal responses to haemorrhage in conscious rats. Reg Peptides 1996; 67: 107-113.
23. Saiki Y et al. Role of central ANG II receptors in stress-induced cardiovascular and hyperthermic responses in rats. Am J Physiol 1997; 272: R26-R33.
24. Raizada MK, Lu D, Sumners C. ATI receptors and angiotensin hypertensive rats. In: Mukhopadhyay AK, Raizada MK (eds). Current Concepts: Tissue Renin-Angiotensin System as Local Regulators in Reproductive and Endocrine Organs. Plenum: New York, 1994, pp 331-348.
25. Tsutsumi K, Saavedra JM. Characterization of AT2 angiotensin II receptor subtypes (ATa and AT2) in rat brain. Am J Physiol 1991; 261: R209-R216.
26. Obermtiler N et al. Distribution of angiotensin II receptor subtypes in rat brain nuclei. Neurosci Lett 1991; 132: 11-14.
27. Gelband CH, Sumners C, Lu D, Raizada MK. Angiotensin receptors and norepinephrine neuromodulation: implications of functional coupling. Reg Peptides 1998; 73: 141-147.
28. Scicli AG, Carretero OA. The brain kallikrein-kinin system. A possible role in blood pressure regulation. Hypertension 1990; 15: 413-414.
29. Fujiwara Y et al. Characterization of [3H]bradykinin binding sites in guinea-pig central nervous system: possible existence of B2 subtypes. Life Sci 1989; 44: 1645-1653.
30. Rodrigo J et al. Localization of nitric oxide synthase in the adult rat brain. Philos Trans R Soc London B Biol Sci 1994; 345: 175-221.
31. Lee JH, Konarska M, McCarty R. Physiological responses to acute stress in alloxan and streptozotocin diabetic rats. Physiol Behav 1989; 45: 483-489.
32. Severs WB, Summy-Long J, Taylor JS, Connor JD. A central effect of angiotensin: release of pituitary pressor material. J Pharmacol Exp Ther 1970; 174: 27-34.
33. Carini DJ et al. Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl) imidazoles as potent, orally active antihypertensives. J Med Chem 1991; 34: 2525-2547.
34. Ganz MB, Perfetto MC, Boron WF. Effects of mitogens and other agents on rat mesangial cell proliferation, pH, and Ca2+. Am J Physiol 1990; 259: F269-F278.
35. Everett AD, Tufro-McReddie A, Fisher A, Gomez RA. Angiotensin receptor regulates cadiac hypertrophy and transforming growth factor-/3a expression. Hypertension 1994; 23: 587-592.
36. Hohle S et al. Angiotensin ATa receptor-mediated vasopressin release and drinking are potentiated by an AT2 receptor antagonist. Eur J Pharmacol 1995; 275: 277-282.
37. Nakajima M et al. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT, receptor: gain of-function study using gene transfer. Proc Natl Acad Sci USA 1995; 92: 10663-10667.
38. Ichiki T et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995; 377: 748-750.
39. Siragy HM, Inagami T, Ichiki T, Carey RM. Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci 1999; 96: 6506-6510.
40. Brix J, Harbel RL. The AT2-receptor mediates endothelium-dependent dilation of rat brain arterioles. FASEB/1992; 6: A1264.
41. Hecker M, Porsti Y, Busse R. Mechanisms involved in the angiotensin II-independent hypotensive action of ACE inhibitors. Braz J Med Biol Bes 1994; 27: 1917-1921.
42. Martin W, Villani GM, Jothianandan D, Furchgott RF. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther 1985; 232: 708-716.
43. Brosnihan KB, Li P, Ferrario CM. Angiotensin-(l-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 1996; 27: 523-528.
44. Liu J-L, Murakami H, Zucker HI. Angiotensin Il-nitric oxide interaction on sympathetic outflow in conscious rabbits. Circ Res 1998; 82: 496-502.
45. Lo W-Ch, Jan ChR, Wu SN, Tseng ChJ. Cardiovascular effects of nitric oxide and adenosine in the nucleus tractus solitari of rats. Hypertension 1998; 32: 1034-1038.
46. Chaki S, Inagami T. New signaling mechanism of angiotensin II in neuroblastoma Neuro-sA cells: activation of soluble guanylyl cyclase via nitric oxide synthesis. Mol Pharmacol 1993; 43: 603-608.
47. Schmid HA, Schafer F, Simon E. Opposite effects of angiotensin II and nitric oxide on neurons in the duck subfornical organ. Neurosci Letters 1995; 187: 149-152.
48. Caligiorne SM, Santos RAS, Campagnole-Santos MJ. Cardiovascular effects produced by bradykinin microinjection into the nucleus tractus solitari of anesthetized rats. Brain Res 1996; 720: 183-190.